These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 9990469

  • 1. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Abraham OC, Manavathu EK, Cutright JL, Chandrasekar PH.
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
    [Abstract] [Full Text] [Related]

  • 2. Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
    Manavathu EK, Abraham OC, Chandrasekar PH.
    Clin Microbiol Infect; 2001 Mar; 7(3):130-7. PubMed ID: 11318811
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    Manavathu EK, Cutright JL, Loebenberg D, Chandrasekar PH.
    J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant Aspergillus Section Fumigati Clinical Isolates.
    Dellière S, Verdurme L, Bigot J, Dannaoui E, Senghor Y, Botterel F, Fekkar A, Bougnoux ME, Hennequin C, Guitard J.
    Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31844011
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
    Verweij PE, Mensink M, Rijs AJ, Donnelly JP, Meis JF, Denning DW.
    J Antimicrob Chemother; 1998 Sep 21; 42(3):389-92. PubMed ID: 9786480
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL, Moore CB, Denning DW.
    Antimicrob Agents Chemother; 1998 Oct 21; 42(10):2726-30. PubMed ID: 9756785
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M, Rodríguez-Tudela JL, Mellado E, Martínez-Suárez JV, Monzón A.
    J Antimicrob Chemother; 1998 Oct 21; 42(4):531-3. PubMed ID: 9818755
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY, Xu YC, Shi Y, Lü HX, Liu Y, Zhao WS, Chen DM, Xi LY, Zhou X, Wang H, Guo LN.
    Chin Med J (Engl); 2010 Oct 21; 123(19):2706-9. PubMed ID: 21034656
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.
    Int J Antimicrob Agents; 2005 Apr 21; 25(4):321-8. PubMed ID: 15784312
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD, Kiraz N.
    Mycoses; 2007 Nov 21; 50(6):447-50. PubMed ID: 17944704
    [Abstract] [Full Text] [Related]

  • 11. In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
    Oakley KL, Moore CB, Denning DW.
    J Antimicrob Chemother; 1998 Jul 21; 42(1):91-4. PubMed ID: 9700534
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
    Gomez-Lopez A, Garcia-Effron G, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M.
    Antimicrob Agents Chemother; 2003 Oct 21; 47(10):3085-8. PubMed ID: 14506013
    [Abstract] [Full Text] [Related]

  • 13. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
    Krishnan-Natesan S, Wu W, Chandrasekar PH.
    Diagn Microbiol Infect Dis; 2012 Jun 21; 73(2):135-7. PubMed ID: 22608136
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Pfaller MA, Duncanson F, Messer SA, Moet GJ, Jones RN, Castanheira M.
    Antimicrob Agents Chemother; 2011 Nov 21; 55(11):5155-8. PubMed ID: 21844312
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.
    Moore CB, Law D, Denning DW.
    J Antimicrob Chemother; 1993 Dec 21; 32(6):831-6. PubMed ID: 8144422
    [Abstract] [Full Text] [Related]

  • 16. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA, Messer SA, Hollis RJ, Jones RN, SENTRY Participants Group.
    Antimicrob Agents Chemother; 2002 Apr 21; 46(4):1032-7. PubMed ID: 11897586
    [Abstract] [Full Text] [Related]

  • 17. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J, Peláez T, Alcalá L, Bouza E.
    Diagn Microbiol Infect Dis; 2007 Mar 21; 57(3):273-6. PubMed ID: 17141455
    [Abstract] [Full Text] [Related]

  • 18. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH.
    J Clin Microbiol; 1999 Dec 21; 37(12):3946-51. PubMed ID: 10565912
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R, Pina-Vaz C, Rodrigues AG.
    Int J Antimicrob Agents; 2007 Jan 21; 29(1):108-11. PubMed ID: 17189101
    [Abstract] [Full Text] [Related]

  • 20. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, Rodriguez-Tudela JL.
    Antimicrob Agents Chemother; 2005 Mar 21; 49(3):1232-5. PubMed ID: 15728937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.